This study investigated if biological disease-modifying anti-rheumatic drugs (bDMARDs) affect diabetes risk in patients with rheumatoid arthritis (RA).

They found that bDMARD use was associated with lower rates of diabetes in these patients. 

This study was carried to examine the effectiveness of using chest computed tomography (CT) for the screening of osteoporosis (OP) and predicting the risk of fractures (bone breaks) in patients with breast cancer (BC). The authors found that CT can be used for predicting OP and determining the risk of fractures in these patients. 

This study investigated the effectiveness and safety of upadacitinib (Rinvoq) to abatacept (Orencia) for patients with rheumatoid arthritis (RA).

The study showed that upadacitinib was more effective in lowering the disease activity score (DAS28) and in decreasing symptoms, but had more side effects compared to abatacept.

The study evaluated whether Breast Cancer Index (BCI) can predict benefits from extended endocrine therapy (EET) in patients with hormone-receptor-positive (HR+) early-stage breast cancer (BC). The authors found that BCI can predict which patients would benefit from 10 years of EET.

This study investigated if weight changes increase the risk of cardiovascular events (CVEs) in patients with rheumatoid arthritis (RA). They found that a 10% increase or decrease in weight increased the risk of CVEs in these patients. 

This study was carried out to look at the risk of developing a second cancer in patients with breast cancer (BC) undergoing statin therapy. The authors found that there was little association between statin use and second cancer risk in these patients.

This study investigated the impact of dietary supplements and diet changes on disease activity score (DAS) in patients with rheumatoid arthritis (RA).

The study showed that some diet types like the Mediterranean diet, some spices and supplements may have positive effects on RA symptoms.

This study investigated the effects of a rehabilitation program on pain, quality of life (QoL), and c-reactive protein (CRP) values for patients with rheumatoid arthritis (RA) and different levels of disease activity score (DAS).

The study found that a rehabilitation program significantly improved pain and QoL for patients, regardless of their DAS.

This trial was carried out to analyze whether the length of time without treatment and the length of time without active disease influences the survival of patients with advanced breast cancer (ABC) spread to the bone taking palbociclib (Ibrance) plus hormonal therapy (HT). The authors concluded that palbociclib plus HT was effective as the standard of care in ABC that has spread to the bone. 

This study observed the effects of physical activity on patients with chronic inflammatory diseases such as rheumatoid arthritis (RA) by using the supervision of a physiotherapist (PT) and additional digital monitoring.

It showed that the multi-component procedures can help improve pain and the level of daily activity in these patients.